Get started
Author

Michelle Shaw

Observed names: M Shaw, M. Shaw, Shaw, Michelle
ORCID: 0000-0002-0966-6779
Observed ORCID: 0000-0002-0966-6779
OpenAlex ID: A5014093725
Lung Clearance Index to Track Acute Respiratory Events in School-Age Children with Cystic Fibrosis
2020 · Lucy Perrem, Sanja Stanojevic, et al. · American Journal of Respiratory and Critical Care Medicine · 53
PDF
Changes in LCI in F508del/F508del patients treated with lumacaftor/ivacaftor: Results from the prospect study
2020 · Michelle Shaw, Umer Khan, et al. · Journal of Cystic Fibrosis · 41
Determinants of lung disease progression measured by lung clearance index in children with cystic fibrosis
2021 · Sanja Stanojevic, Stephanie D. Davis, et al. · European Respiratory Journal · 30
PDF
Impact of antibiotic eradication therapy of Pseudomonas aeruginosa on long term lung function in cystic fibrosis
2022 · Isabel Gascon Casaredi, Michelle Shaw, et al. · Journal of Cystic Fibrosis · 22
The Impact of Age of Diagnosis in Children with Primary Ciliary Dyskinesia
2024 · Dvir Gatt, Michelle Shaw, et al. · Annals of the American Thoracic Society · 20
Efficacy of Antibiotic Eradication Therapy of Early Pseudomonas aeruginosa Infection in Children with Primary Ciliary Dyskinesia
2023 · Dvir Gatt, Michelle Shaw, et al. · Annals of the American Thoracic Society · 20
Genetic evidence supports the development of SLC26A9 targeting therapies for the treatment of lung disease
2022 · Jiafen Gong, Gengming He, et al. · npj Genomic Medicine · 18
PDF
Relationship between theratyping in nasal epithelial cells and clinical outcomes in people with cystic fibrosis
2025 · Felix Ratjen, Sanja Stanojevic, et al. · European Respiratory Journal · 17
A randomised trial of oral prednisone for cystic fibrosis pulmonary exacerbation treatment
2024 · Valerie Waters, Michelle Shaw, et al. · European Respiratory Journal · 16
Treatment response to pulmonary exacerbation in primary ciliary dyskinesia
2023 · Dvir Gatt, Michelle Shaw, et al. · Pediatric Pulmonology · 16
Longitudinal Assessment of Curaçao Criteria in Children with Hereditary Hemorrhagic Telangiectasia
2023 · Mordechai Pollak, Dvir Gatt, et al. · The Journal of Pediatrics · 14
Cardiopulmonary Exercise Testing Provides Prognostic Information in Advanced Cystic Fibrosis Lung Disease
2023 · Thomas Radtke, Don S. Urquhart, et al. · Annals of the American Thoracic Society · 13
The utility of moment ratios and abbreviated endpoints of the multiple breath washout test in preschool children with cystic fibrosis
2020 · Michelle Shaw, Martinus C. Oppelaar, et al. · Pediatric Pulmonology · 11
The effect of antibiotic changes during treatment of cystic fibrosis pulmonary exacerbations
2022 · Andrew Zikic, Felix Ratjen, et al. · Journal of Cystic Fibrosis · 9
Changes in the parent cystic fibrosis questionnaire-revised (CFQ-R) with respiratory symptoms in preschool children with cystic fibrosis
2020 · Lucy Perrem, Sanja Stanojevic, et al. · Journal of Cystic Fibrosis · 9
PDF
CFTR-function and ventilation inhomogeneity in individuals with cystic fibrosis
2020 · Nadine Bernasconi, Elisabeth Kieninger, et al. · Journal of Cystic Fibrosis · 8
PDF
Lung Function Recovery from Pulmonary Exacerbations Treated with Oral Antibiotics in Primary Ciliary Dyskinesia
2024 · Dvir Gatt, Michelle Shaw, et al. · Annals of the American Thoracic Society · 7
Comparative analysis of respiratory symptom scores to detect acute respiratory events in children with cystic fibrosis
2022 · Lucy Perrem, Sanja Stanojevic, et al. · Journal of Cystic Fibrosis · 6
Re: Impact of spiroware re-analysis method on multiple-breath washout outcomes in children with cystic fibrosis; M.A. Oestreich, F. Wyler, P. Latzin et al.
2022 · Renee Jensen, Michelle Shaw, et al. · Journal of Cystic Fibrosis · 5
PDF
Early determinants of lung disease in children with cystic fibrosis
2020 · Sanja Stanojevic, Stephanie Davis, et al. · European Respiratory Journal · 5
SPLUNC1 as a biomarker of pulmonary exacerbations in children with cystic fibrosis
2024 · E. Ben-Meir, L. Perrem, et al. · Journal of Cystic Fibrosis · 4
Factors associated with lung function response with oral antibiotic treatment of pulmonary exacerbations in cystic fibrosis
2023 · Ana C. Blanchard, Michelle Shaw, et al. · Journal of Cystic Fibrosis · 4
PDF
Interleukin-1 beta is a potential mediator of airway nitric oxide deficiency in cystic fibrosis
2022 · Gyde Nissen, Elad Ben-Meir, et al. · Journal of Cystic Fibrosis · 4
Feasibility and Utility of Multiple Breath Washout Measured Scond and Sacin in Preschool Children With Cystic Fibrosis
2025 · James Lynch, Renee Jensen, et al. · Pediatric Pulmonology · 3
PDF
Disease Manifestations in Siblings with Primary Ciliary Dyskinesia
2023 · Dvir Gatt, Michelle Shaw, et al. · Annals of the American Thoracic Society · 3
Works count: 57
Citation count: 375
H-index: 12
I10-index: 13
Year
Topic
Type